HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decreased Striatal Vesicular Monoamine Transporter Type 2 Correlates With the Nonmotor Symptoms in Parkinson Disease.

AbstractOBJECTIVE:
Nonmotor symptoms (NMS) are critical players in the patients' quality of life in Parkinson disease (PD). Vesicular monoamine transporter type 2 (VMAT2) has been reported owing to a role in affecting dopamine neurons in the striatum. Therefore, this study set out to characterize the relationship between VMAT2 distribution in the striatum in relation to the NMS in PD.
METHODS:
Totally, 21 age-matched normal controls and 37 patients with PD in the moderate stages were included, followed by examination using F-DTBZ (F-AV133) PET/CT. The specific uptake ratio (SUR) of each striatal subregion was then determined with the occipital cortex as the reference background region. The overall NMSs of each individual patient were evaluated. Finally, the role of the striatal SURs in the clinical symptom scores were evaluated through the application of a Spearman correlation analysis as well as a multivariable stepwise regression analysis.
RESULTS:
Patients with PD, particularly those at a more advanced stage, exhibited a more pronounced reduction in SURs in the bilateral putamen and caudate nucleus (P < 0.05, vs healthy controls). Meanwhile, patients at more advanced PD stages were found to have significantly worse scores in NMS except cognitive function. The Spearman correlation analysis demonstrated that NMS scores, with the exception of cognition scores, were correlated with striatal SURs (P < 0.05).
CONCLUSION:
The key findings of the study identified a correlation between decreased striatal VMAT2 with a broad spectrum of NMS in patients with PD, highlighting the association between diminished dopamine supply and the development of NMS in PD.
AuthorsXinchong Shi, Yan Zhang, Shaohua Xu, Hank F Kung, Hongwen Qiao, LuLu Jiang, Lin Zhu, Qiyi Guo, Chang Yi, Ganhua Luo, Lei Wu, Zhong Pei, Jian Wang, Xiangsong Zhang, Ling Chen
JournalClinical nuclear medicine (Clin Nucl Med) Vol. 44 Issue 9 Pg. 707-713 (Sep 2019) ISSN: 1536-0229 [Electronic] United States
PMID31205154 (Publication Type: Journal Article)
Chemical References
  • SLC18A2 protein, human
  • Vesicular Monoamine Transport Proteins
Topics
  • Aged
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neostriatum (metabolism)
  • Parkinson Disease (diagnostic imaging, metabolism, physiopathology)
  • Positron Emission Tomography Computed Tomography
  • Quality of Life
  • Vesicular Monoamine Transport Proteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: